文献速递妇科

美国新墨西哥州基于人群的宫颈癌机会性筛查期间发病评估

A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States.
PubMed 文献 · Gynecol Oncol · 2020-09-22

该研究评估了2006至2016年新墨西哥州25-64岁宫颈癌患者的筛查史,发现64%在诊断前5-40个月未筛查或筛查不足,仅32%的宫颈癌为筛查发现,当前筛查预防35%的癌症,而全面覆盖可预防61%。

要点

  • 64%的宫颈癌患者在诊断前5-40个月未筛查或筛查不足。
  • 仅32%的宫颈癌为筛查发现,腺癌患者近期阴性筛查比例高于鳞癌。
  • 当前筛查预防35%的宫颈癌,全面覆盖可预防61%。

核心结论

  • 提高筛查覆盖率对降低宫颈癌发病率潜力最大,但改进召回流程和筛查灵敏度也有作用。

研究设计与样本

  • 基于人群的评估,收集2006至2016年新墨西哥州25-64岁所有宫颈癌患者的筛查、诊断和治疗数据。
  • 504名女性于2009年5月至2016年12月期间诊断。

主要发现

  • 64%的女性在诊断前5-40个月未筛查或仅有不充分的筛查测试。
  • 182名筛查女性中90名(49%)在该期间仅有阴性筛查结果。
  • 仅32%(N=162)的宫颈癌为筛查发现。
  • 腺癌女性近期阴性筛查比例为41/57=722%,鳞癌女性为50/112=45%。
  • 当前筛查预防35%的癌症,全面筛查覆盖可预防61%的宫颈癌。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite widespread cervical screening, an estimated 13,800 women will be diagnosed with cervical cancer in the United States in 2020. To inform improvements, the screening histories of women diagnosed with cervical cancer in New Mexico were assessed. METHODS: Data were collected on all cervical screening, diagnostic tests and treatment procedures for all women diagnosed with cervical cancer aged 25-64 yrs. in New Mexico from 2006 to 2016. Women were categorized by their screening attendance in the 5-40 months (screening interval) and 1-4 months (peri-diagnostic interval) prior to cancer diagnosis. RESULTS: Of the 504 women diagnosed between May 2009-December 2016, 64% were not screened or had only inadequate screening tests in the 5-40 months prior to diagnosis, and 90 of 182 screened women (49%) had only negative screens in this period. Only 32% (N = 162) of cervical cancers were screen-detected. Women with adenocarcinomas were more likely to have had a recent negative screen (41/57 = 722%) than women with squamous cancers (50/112 = 45%). Both older women (aged 45-64 years) and women with more advanced cancers were less likely to have been screened, and if screened, were more likely to have a false-negative outcome. Only 9% of cancers were diagnosed in women who did not attend biopsy or treatment after positive tests requiring clinical management. Screening currently prevents 35% of cancers, whereas full screening coverage could prevent 61% of cervical cancers. CONCLUSION: Improved screening coverage has the largest potential for reducing cervical cancer incidence, though there is also a role for improved recall procedures and screening sensitivity.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Landy R, Mathews C, Robertson M, et al. A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States. Gynecol Oncol. 2020. PMID: 32977987. doi:10.1016/j.ygyno.2020.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。